{"disease":{"id":"subcutaneous-fat","name":"subcutaneous fat"},"drugs":{"marketed":[{"drug_id":"deoxycholic-acid","indication_name":"Excess subcutaneous fat","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Kybella","generic_name":"DEOXYCHOLIC ACID","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"G-protein coupled bile acid receptor 1","drug_class":"Cytolytic Agent [EPC]","quality_score":65,"revenue":null,"mechanism":"Kybella works by targeting and destroying excess fat cells through a process that involves disrupting the cell membrane."},{"drug_id":"kybella","indication_name":"Excess subcutaneous fat","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Kybella","company_name":"Massachusetts General Hospital","drug_phase":"marketed","molecular_target":"G-protein coupled bile acid receptor 1, fMet-Leu-Phe receptor, Bile acid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03682471","title":"Long-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection)","phase":"","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Allergan","has_results":false},{"nct_id":"NCT06005441","title":"A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":173,"lead_sponsor_name":"Caliway Biopharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT05736107","title":"A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"Caliway Biopharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT03875625","title":"Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention","phase":"NA","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT05155683","title":"Combination of Light and Ultrasound to Reduce Abdominal Fat","phase":"NA","overall_status":"COMPLETED","enrollment_count":79,"lead_sponsor_name":"University of Nove de Julho","has_results":false},{"nct_id":"NCT04897412","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Caliway Biopharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT04206384","title":"Low-Frequency, High-Intensity Ultrasound for Waist Circumference Reduction","phase":"NA","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"CAO Group, Inc.","has_results":true},{"nct_id":"NCT04698642","title":"A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Caliway Biopharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT04699669","title":"A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Caliway Biopharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT03871556","title":"Diagnostic Ultrasound for Measuring Fat of the Body","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Northwestern University","has_results":true},{"nct_id":"NCT03160976","title":"Cryolipolysis on Localized Adiposity","phase":"NA","overall_status":"UNKNOWN","enrollment_count":28,"lead_sponsor_name":"Federal University of Health Science of Porto Alegre","has_results":false},{"nct_id":"NCT04575467","title":"A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Caliway Biopharmaceuticals Co., Ltd.","has_results":true},{"nct_id":"NCT05760248","title":"Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"10xBio, LLC","has_results":false},{"nct_id":"NCT05234736","title":"A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Caliway Biopharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT04553627","title":"Feasibility of Producing the Appearance of a Gluteal Lift Post Cryolipolysis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"Riverchase Dermatology","has_results":false},{"nct_id":"NCT04090853","title":"Subject Evaluation of a 1064nm Diode Laser/RF","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Venus Concept","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}